METHODS OF TREATING RESIDUAL BREAST CANCER WITH TRASTuzumab emtansine

CY1125766T1Undetermined Publication Date: 2026-04-17F HOFFMANN LA ROCHE & CO AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CY20231100043T
Authority / Receiving Office
CY · CY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-10-15
Filing Date
2023-01-26
Publication Date
2026-04-17
Estimated Expiration
2043-01-26
Patent Text Reader

Abstract

Methods of treating patients who have HER2-positive early breast cancer with the antibody-drug conjugate trastuzumab emtansine (T-DM1) are provided.
Need to check novelty before this filing date? Find Prior Art